Ozempic Face
common.weeks_ago
Many people using GLP-1 agonists for weight loss experience a loss of facial volume, which causes their skin to sag—commonly referred to as 'Ozempic face.' To address this loss, there are various treatment options: hyaluronic acid fillers, new fat-creating fillers, and platelet-rich plasma (PRP) from the patient's own blood. While these help restore volume, additional devices like radiofrequency and ultrasound can tighten sagging skin without the need for surgery.
Ozempic face: A term used to describe facial volume loss and sagging skin that can occur when people lose weight rapidly, especially while taking medications like Ozempic (a GLP-1 agonist).
GLP-1 agonists: A class of medications used to treat diabetes and obesity by mimicking the GLP-1 hormone, which lowers appetite. Examples include Ozempic, Mongero, ZepBound, and Wegovy.
hyaluronic acid fillers: Injectable gels used for decades to restore lost volume in the face by filling wrinkles and plumping cheeks.
PRP (platelet-rich plasma): A treatment where a patient's own blood is processed to concentrate platelets, which is then injected into the skin or used as a filler to help with volume restoration.
radiofrequency devices: Medical devices that use radiofrequency energy to heat the deeper layers of the skin, stimulating collagen production and tightening the skin.
ultrasound devices: Devices that use focused ultrasound energy to stimulate collagen production and tighten sagging skin without surgery.